These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 10912746)

  • 21. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
    Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
    J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily monotherapy with trandolapril in the treatment of hypertension.
    Smith DH; Neutel JM; Black HR; Schoenberger JA; Weber MA
    J Hum Hypertens; 1996 Feb; 10(2):129-34. PubMed ID: 8867568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F; Vaur L; Dutrey-Dupagne C; Genes N; Clerson P
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
    Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril.
    Bauduceau B; Genès N; Chamontin B; Vaur L; Renault M; Etienne S; Marre M
    Am J Hypertens; 1998 Sep; 11(9):1065-73. PubMed ID: 9752891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Office and 24-h ambulatory blood pressure control by treatment in general practice: the 'Monitoraggio della pressione ARteriosa nella medicina TErritoriale' study.
    Zaninelli A; Parati G; Cricelli C; Bignamini AA; Modesti PA; Pamparana F; Bilo G; Mancia G; Gensini GF;
    J Hypertens; 2010 May; 28(5):910-7. PubMed ID: 20139769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Duration of action of trandolapril in mild to moderate hypertensive patients evaluated by ambulatory measurement of blood pressure].
    Kownator S; Dutrey-Dupagne C; Vaur L; Chevrier J; Diesel J; D'Hotel R; Schaaf R; Courvoisier A; Breton C
    Therapie; 1994; 49(2):89-93. PubMed ID: 7817355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permanent blood pressure control over the 24 h by trandolapril.
    Omboni S; Ravogli A; Villani A; Mancia G
    Am J Hypertens; 1995 Oct; 8(10 Pt 2):71S-74S. PubMed ID: 8845088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the antihypertensive efficacy of various doses of delapril by office and ambulatory blood pressure measurement: the DEFIND study.
    Otero ML; Parisi G; Maffei A; Vecchione C; Lembo G;
    Adv Ther; 2006; 23(3):421-32. PubMed ID: 16912024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure control in anticoagulated hypertensive patients.
    Guzet F; Bitigen A; Karabay CY; Cimen AO; Teyfik N
    Blood Press Monit; 2015 Feb; 20(1):20-6. PubMed ID: 25243710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future developments in ambulatory blood pressure monitoring and self-blood pressure monitoring in clinical practice.
    Pickering T
    Blood Press Monit; 2002 Feb; 7(1):21-5. PubMed ID: 12040238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
    Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
    J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.